NIH-funded research R01 grant

Improving HIV prevention strategies in Botswana

Official title: Evaluation of PrEP implementation strategies for the general population in Botswana

Funded at University of Botswana · NIH-11161430 · Data updated 2026-11-12

This study is all about finding better ways to help people in Botswana learn about and access PrEP, a medication that can prevent HIV, especially focusing on younger folks who are often on the move and use technology a lot.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Botswana
NIH-funded
Lab location1 site (Gaborone, Botswana)
Project startAugust 5, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$644,944
NIH project number5R01MH134784-02
Project IDNIH-11161430 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include young adults and adolescents in Botswana who are at risk of HIV infection and are seeking preventive options.

Less likely to help

Patients who are already HIV positive or those who do not have access to healthcare facilities in Botswana may not benefit from this research.

What this research studies

This research focuses on developing and testing new strategies to improve the implementation of pre-exposure prophylaxis (PrEP) for HIV prevention among the general population in Botswana. It aims to address barriers to PrEP uptake, such as lack of knowledge and social support, particularly targeting younger, mobile, and digitally connected individuals. The study will collaborate with policymakers and healthcare providers to create effective outreach and education programs. By leveraging existing healthcare infrastructure, the research seeks to enhance access to PrEP and ultimately reduce new HIV infections.

Why it matters

Potential benefit: If successful, this research could significantly reduce the rate of new HIV infections in Botswana by improving access to preventive treatments.

How similar studies have gone: Previous research has shown success in implementing PrEP strategies in targeted populations, indicating potential for positive outcomes in broader populations as well.

Where this research is happening

  • University of Botswana
    Gaborone, Botswana
    Active

Researchers

  • Principal investigator: Mosepele, Mosepele — University of Botswana
  • Study coordinator: Mosepele, Mosepele

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.